← ANALYSTS · TIPRANKS
David Amsellem · Piper Sandler
Hits
62%
309 of 499 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+15.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
21
Buy / hold / sell: 17 / 4 / 0
Upside of the analyst’s targets
+42.1%
Average over 21 current targets, to the last price
The market’s answer to the ratings
−0.4%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks 07:10 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $82.00 | +37.2% | −1.6%next day +5.7% | ↗ |
| Oct 12on TipRanks 06:55 | VTRSSPYViatris · $20.9B | Reiterated | Hold | $13.00 | −30.3% | −0.5%next day −1.6% | ↗ |
| Oct 12on TipRanks 06:55 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $245 | +5.3% | +1.7%next day −0.2% | ↗ |
| Oct 9on TipRanks 07:11 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $210 | +54.7% | +0.2%next day −0.7% · 5 days −2.8% | ↗ |
| Oct 9on TipRanks 07:11 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $82.00 | +37.2% | −1.4%next day −2.5% · 5 days +3.0% | ↗ |
| Oct 8on TipRanks 07:07 | ABBVSPYAbbVie · $501B | Reiterated | Buy | $303 | +6.2% | +0.8%next day +0.9% · 5 days +4.9% | ↗ |
| Oct 7on TipRanks 07:25 | CORTCorcept Therapeutics · $12.9B | Reiterated | Buy | $165 | +49.8% | +0.3%next day −0.5% · 5 days −1.8% | ↗ |
| Oct 5on TipRanks 07:56 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $245 | +5.3% | +1.0%next day −0.9% · 5 days +2.2% | ↗ |
| Oct 5on TipRanks 07:56 | AMGNQQQSPYAmgen · $235B | Reiterated | Buy | $457 | +5.7% | −0.7%next day −0.6% · 5 days +3.2% | ↗ |
| Oct 1on TipRanks 07:08 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $210 | +54.7% | −1.0%next day +1.0% · 5 days −0.9% | ↗ |
| Sep 28on TipRanks 07:00 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $310 | +47.5% | +0.9%next day −2.3% · 5 days −2.1% | ↗ |
| Sep 23on TipRanks 08:15 | ABBVSPYAbbVie · $501B | Reiterated | Buy | $303 | +6.2% | +0.7%next day +0.1% · 5 days −0.6% | ↗ |
| Sep 23on TipRanks 08:15 | AMGNQQQSPYAmgen · $235B | Reiterated | Buy | $457 | +5.7% | −0.3%next day +0.1% · 5 days +4.5% | ↗ |
| Sep 18on TipRanks 07:10 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $258 | +64.2% | −3.2%next day −2.7% · 5 days −7.4% | ↗ |
| Sep 16on TipRanks 07:10 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $75.00 → $82.00+9.3% | +37.2% | +0.2%next day −2.3% · 5 days −5.9% | ↗ |
| Sep 16on TipRanks 07:10 | VTRSSPYViatris · $20.9B | Reiterated | Hold | $12.00 → $13.00+8.3% | −30.3% | +2.7%next day −0.5% · 5 days −1.5% | ↗ |
| Sep 10on TipRanks 07:10 | XERSIWMXeris Pharmaceuticals · $1.8B | Reiterated | Hold | $8.00 | −22.4% | +0.1%next day −3.7% · 5 days +5.8% | ↗ |
| Sep 3on TipRanks 06:50 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $225 → $245+8.9% | +5.3% | −0.2%next day −1.3% · 5 days −2.1% | ↗ |
| Aug 21on TipRanks 06:45 | CORTCorcept Therapeutics · $12.9B | Reiterated | Buy | $165 | +49.8% | +0.6%next day +1.1% · 5 days −7.3% | ↗ |
| Aug 17on TipRanks 07:37 | DFTXIWMDefinium Therapeutics · $4.6B | Reiterated | Buy | $75.00 | +133.6% | +6.6%next day +2.7% · 5 days −3.2% | ↗ |
| Aug 7on TipRanks 08:01 | AMPHIWMAmphastar Pharmaceuticals · $1.1B | Reiterated | Hold | $21.00 → $20.00−4.8% | −22.7% | +4.3%next day −2.2% · 5 days +0.2% | ↗ |
| Aug 7on TipRanks 08:01 | COLLIWMCollegium Pharmaceutical · $733M | Reiterated | Hold | $45.00 → $43.00−4.4% | +85.4% | +0.6%next day −7.7% · 5 days −4.6% | ↗ |
| Aug 6on TipRanks 07:01 | ALKSIWMAlkermes · $6.7B | Reiterated | Buy | $65.00 | +57.7% | −2.3%next day +1.0% · 5 days +1.0% | ↗ |
| Jul 27on TipRanks 10:19 | SUPNIWMSupernus Pharmaceuticals · $2.3B | Reiterated | Buy | $66.00 | +74.2% | +1.7%next day +1.4% · 5 days −4.6% | ↗ |
| Jul 20on TipRanks Jul 24 05:08 | AMRXIWMAmneal Pharmaceuticals · $6.1B | Reiterated | Buy | $17.00 | −11.4% | −1.8%next day +2.6% · 5 days +3.8% | ↗ |
| May 22on TipRanks 07:25 | INDVIWMIndivior · $4.0B | Reiterated | Buy | $54.00 → $59.00+9.3% | +81.8% | −0.2%next day +0.1% · 5 days −8.8% | ↗ |
| May 15on TipRanks 07:00 | AQSTIWMAquestive Therapeutics · $579M | Reiterated | Buy | $8.00 | +111.6% | −10.6%next day −0.8% · 5 days −2.1% | ↗ |
| May 15on TipRanks 07:00 | FENCIWMFennec Pharmaceuticals · $350M | Reiterated | Buy | $18.00 | +80.4% | +6.7%next day −1.5% · 5 days +1.0% | ↗ |
| Apr 23on TipRanks 07:35 | ANIPIWMANI Pharmaceuticals · $1.7B | Reiterated | Buy | $111 | +53.5% | −2.2%next day 0.0% · 5 days +0.3% | ↗ |
| Apr 22on TipRanks 07:06 | HRMYIWMHarmony Biosciences Holdings · $2.2B | Reiterated | Buy | $46.00 | +21.2% | −1.5%next day +0.7% · 5 days −2.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗